NeuroTransit Overview

  • Founded
  • 2008
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

NeuroTransit General Information

Description

Owner and operator of a bio pharmaceutical company intended to offer therapeutics for neurologic, metabolic and oncologic diseases. The company bio pharmaceutical services include using proprietary technology for the development of drug products that cross the blood-brain barrier, enabling patients to avail treatment for neurologic, metabolic and oncologic diseases of the brain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 6020 Cornerstone West Court
  • Suite 200
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroTransit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business Completed Out of Business
2. Early Stage VC 01-Jan-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view NeuroTransit’s complete valuation and funding history, request access »

NeuroTransit Executive Team (2)

Name Title Board Seat Contact Info
Michael Dunn Co-Founder, President and Chief Executive Officer
To view NeuroTransit’s complete executive team members history, request access »